| __timestamp | BioCryst Pharmaceuticals, Inc. | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 13608000 | 9757000 |
| Thursday, January 1, 2015 | 48257000 | 1253000 |
| Friday, January 1, 2016 | 26353000 | 5421000 |
| Sunday, January 1, 2017 | 25186000 | 154584000 |
| Monday, January 1, 2018 | 20653000 | 301034000 |
| Tuesday, January 1, 2019 | 48835000 | 380833000 |
| Wednesday, January 1, 2020 | 17812000 | 540099000 |
| Friday, January 1, 2021 | 157170000 | 701887000 |
| Saturday, January 1, 2022 | 270827000 | 933013000 |
| Sunday, January 1, 2023 | 331412000 | 1243336000 |
Data in motion
In the dynamic world of biotechnology, revenue growth is a key indicator of a company's success and potential. Over the past decade, Sarepta Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc. have showcased contrasting yet fascinating revenue trajectories.
From 2014 to 2023, Sarepta Therapeutics experienced a staggering growth, with revenue surging by over 12,000%, reaching approximately $1.24 billion in 2023. This remarkable increase highlights Sarepta's strategic advancements and market penetration. In contrast, BioCryst Pharmaceuticals, while also growing, saw a more modest increase of around 2,300%, culminating in a revenue of about $331 million in 2023.
These figures underscore the competitive nature of the biotech industry, where innovation and strategic positioning can lead to exponential growth. As we look to the future, both companies remain pivotal players in the biotech landscape, each with unique paths to success.
Revenue Showdown: Eli Lilly and Company vs Sarepta Therapeutics, Inc.
Dr. Reddy's Laboratories Limited or Sarepta Therapeutics, Inc.: Who Leads in Yearly Revenue?
Sarepta Therapeutics, Inc. vs Walgreens Boots Alliance, Inc.: Annual Revenue Growth Compared
Revenue Insights: Sarepta Therapeutics, Inc. and Exelixis, Inc. Performance Compared
Breaking Down Revenue Trends: Sarepta Therapeutics, Inc. vs Jazz Pharmaceuticals plc
Sarepta Therapeutics, Inc. vs Mesoblast Limited: Annual Revenue Growth Compared
Revenue Insights: Sarepta Therapeutics, Inc. and Travere Therapeutics, Inc. Performance Compared
Comparing Revenue Performance: Sarepta Therapeutics, Inc. or Galapagos NV?
Corcept Therapeutics Incorporated vs BioCryst Pharmaceuticals, Inc.: Examining Key Revenue Metrics
Comparing Revenue Performance: Cytokinetics, Incorporated or BioCryst Pharmaceuticals, Inc.?
Alkermes plc vs BioCryst Pharmaceuticals, Inc.: Examining Key Revenue Metrics
Breaking Down Revenue Trends: Amphastar Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.